XML 19 R2.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Operations - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]      
Net sales $ 5,782 $ 6,078 $ 6,831
Cost of goods sold 4,631 4,772 5,215
Gross profit 1,151 1,306 1,616
Selling, general, and administrative expense 585 1,290 710
Research and development expense 109 108 118
Restructuring, asset-related, and other charges 60 153 16
Goodwill impairment charge 56    
Total other operating expenses 810 1,551 844
Equity in earnings of affiliates 43 45 55
Interest expense, net (264) (208) (163)
(Loss) gain on extinguishment of debt (1) (1) 7
Other income, net 8 91 70
Income (loss) before income taxes 127 (318) 741
Provision for (benefit from) income taxes 41 (81) 163
Net income (loss) 86 (237) 578
Less: Net income attributable to non-controlling interests   1  
Net income (loss) attributable to Chemours $ 86 $ (238) $ 578
Per share data      
Basic earnings (loss) per share of common stock $ 0.58 $ (1.60) $ 3.72
Diluted earnings (loss) per share of common stock $ 0.57 $ (1.60) $ 3.65